Micro Interventional Devices Submits CE Mark Technical Documentation for the MIA-T Percutaneous Tricuspid Annuloplasty System
The receipt of a CE Mark would allow MID to commercialize MIA-T in the European Union in countries governed by the European Medical Device Regulations (MDR). MID is anticipating an approval in 2021.
Micro Interventional Devices, Inc.™ Successfully Treats First-in-Human Patient with Percutaneous MIA™, Minimally Invasive Annuloplasty Technology
"The percutaneous MIA system has the potential to be a safe and effective intervention for patients with moderate to severe tricuspid regurgitation," stated Prof. Audrius Aidieitis, MD.